Skip to main content Accessibility help
×
Home

The antidepressant standoff: why it continues and how to resolve it

  • Johan Ormel (a1) (a2), Philip Spinhoven (a2) (a3), Ymkje Anna de Vries (a4), Angélique O. J. Cramer (a2) (a5), Greg J. Siegle (a6), Claudi L. H. Bockting (a2) (a7) and Steven D. Hollon (a8)...

Abstract

Background

Antidepressant medications (ADMs) are widely used and long-term use is increasing. Given this extensive use and recommendation of ADMs in guidelines, one would expect ADMs to be universally considered effective. Surprisingly, that is not the case; fierce debate on their benefits and harms continues. This editorial seeks to understand why the controversy continues and how consensus can be achieved.

Methods

‘Position’ paper. Critical analysis and synthesis of relevant literature.

Results

Advocates point at ADMs impressive effect size (number needed to treat, NNT = 6–8) in acute phase treatment and continuation/maintenance ADM treatment prevention relapse/recurrence in acute phase ADM responders (NNT = 3–4). Critics point at the limited clinically significant surplus value of ADMs relative to placebo and argue that effectiveness is overstated. We identified multiple factors that fuel the controversy: certainty of evidence is low to moderate; modest efficacy on top of strong placebo effects allows critics to focus on small net efficacy and advocates on large gross efficacy; ADM withdrawal symptoms masquerade as relapse/recurrence; lack of association between ADM treatment and long-term outcome in observational databases. Similar problems affect psychological treatments as well, but less so. We recommend four approaches to resolve the controversy: (1) placebo-controlled trials with relevant long-term outcome assessments, (2) inventive analyses of observational databases, (3) patient cohort studies including effect moderators to improve personalized treatment, and (4) psychological treatments as universal first-line treatment step.

Conclusions

Given the public health significance of depression and increased long-term ADM usage, new approaches are needed to resolve the controversy.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      The antidepressant standoff: why it continues and how to resolve it
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      The antidepressant standoff: why it continues and how to resolve it
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      The antidepressant standoff: why it continues and how to resolve it
      Available formats
      ×

Copyright

Corresponding author

Author for correspondence: Johan Ormel, E-mail: J.ormel@umcg.nl

References

Hide All
Antonuccio, D., Danton, W., DeNelsky, G., Greenberg, R., & Gordon, J. (1999). Raising questions about antidepressants. Psychotherapy and Psychosomatics, 68(1), 314.
Austin, P. C. (2011). An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behavioral Research, 46(3), 399424.
Barth, J., Munder, T., Gerger, H., Nueesch, E., Trelle, S., Znoj, H., et al. (2013). Comparative efficacy of seven psychotherapeutic interventions for patients with depression: a network meta-analysis. PLoS Medicine, 10(5), e1001454.
Bech, P. (2010). Is the antidepressive effect of second-generation antidepressants a myth? Psychological Medicine, 40(2), 181186.
Bockting, C. L., Hollon, S. D., Jarrett, R. B., Kuyken, W., & Dobson, K. (2015). A lifetime approach to major depressive disorder: The contributions of psychological interventions in preventing relapse and recurrence. Clinical Psychology Review, 41, 1626.
Bockting, C. L. H., Klein, N. S., Elgersma, H. J., van Rijsbergen, G. D., Slofstra, C., Ormel, J., et al. (2018). Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): A three-group, multicentre, randomised controlled trial. The Lancet. Psychiatry, 5(5), 401410.
Boerema, A. M., ten Have, M., Kleiboer, A., de Graaf, R., Nuyen, J., Cuijpers, P., & Beekman, A. T. F. (2017). Demographic and need factors of early, delayed and no mental health care use in major depression: A prospective study. BMC Psychiatry, 17, 367.
Borges, S., Chen, Y., Laughren, T. P., Temple, R., Patel, H. D., David, P. A., … Khin, N. A. (2014). Review of maintenance trials for major depressive disorder: A 25-year perspective from the US food and drug administration. Journal of Clinical Psychiatry, 75(3), 205214.
Bridge, J., Barbe, R., Birmaher, B., Kolko, D., & Brent, D. (2005). Emergent suicidality in a clinical psychotherapy trial for adolescent depression. American Journal of Psychiatry, 162(11), 2173–21U2.
Brodaty, H., Luscombe, G., Peisah, C., Anstey, K., & Andrews, G. (2001). A 25-year longitudinal, comparison study of the outcome of depression. Psychological Medicine, 31(8), 13471359.
Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., … Geddes, J. R. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. Lancet, 391(10128), 13571366.
Clark, D. M. (2018). Realizing the mass public benefit of evidence-based psychological therapies: The IAPT program. Annual Review of Clinical Psychology, 14, 159183.
Cohen, Z. D., & DeRubeis, R. J. (2018). Treatment selection in depression. Annual Review of Clinical Psychology, 14, 209236.
Cooney, G. M., Dwan, K., Greig, C. A., Lawlor, D. A., Rimer, J., Waugh, F. R., et al. (2013). Exercise for depression. Cochrane Database of Systematic Reviews (9), CD004366.
Cuijpers, P., Berking, M., Andersson, G., Quigley, L., Kleiboer, A., & Dobson, K. S. (2013a). A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie, 58(7), 376385.
Cuijpers, P., & Cristea, I. A. (2015). What if a placebo effect explained all the activity of depression treatments? World Psychiatry, 14(3), 310311.
Cuijpers, P., Cristea, I. A., Karyotaki, E., Reijnders, M., & Huibers, M. J. H. (2016). How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence. World Psychiatry, 15(3), 245258.
Cuijpers, P., Hollon, S. D., van Straten, A., Bockting, C., Berking, M., & Andersson, G. (2013b). Does cognitive behaviour therapy have an enduring effect that is superior to keeping patients on continuation pharmacotherapy? A meta-analysis. BMJ Open, 3(4), e002542.
Cuijpers, P., Karyotaki, E., Weitz, E., Andersson, G., Hollon, S. D., & van Straten, A. (2014). The effects of psychotherapies for major depression in adults on remission, recovery and improvement: A meta-analysis. Journal of Affective Disorders, 159, 118126.
Cuijpers, P., van Straten, A., van Oppen, P., & Andersson, G. (2008). Are psychological and pharmacologic interventions equally effective in the treatment of adult depressive disorders? A meta-analysis of comparative studies. Journal of Clinical Psychiatry, 69(11), 16751685.
Davidson, J., Gadde, K., Fairbank, J., Krishnan, R., Califf, R., Binanay, C., et al. (2002). Effect of Hypericum perforatum (St John's wort) in major depressive disorder – a randomized controlled trial. JAMA: Journal of the American Medical Association, 287(14), 18071814.
DeRubeis, R. J., Cohen, Z. D., Forand, N. R., Fournier, J. C., Gelfand, L. A., & Lorenzo-Luaces, L. (2014). The personalized advantage index: Translating research on prediction into individualized treatment recommendations. A demonstration. PLoS ONE, 9(1), e83875.
Deshauer, D., Moher, D., Fergusson, D., Moher, E., Sampson, M., & Grimshaw, J. (2008). Selective serotonin reuptake inhibitors for unipolar depression: a systematic review of classic long-term randomized controlled trials. Canadian Medical Association Journal, 178(10), 12931301.
Detke, M., Wiltse, C., Mallinckrodt, C., McNamara, R., Demitrack, M., & Bitter, I. (2004). Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. European Neuropsychopharmacology, 14(6), 457470.
Driessen, E., Hollon, S. D., Bockting, C. L. H., Cuijpers, P., & Turner, E. H. (2015). Does publication bias inflate the apparent efficacy of psychological treatment for major depressive disorder? A systematic review and meta-analysis of US national institutes of health-funded trials. PLoS ONE, 10(9), e0137864.
Eaton, W. W., Shao, H., Nestadt, G., Lee, B. H., Bienvenu, O. J., & Zandi, P. (2008). Population-based study of first onset and chronicity in major depressive disorder. Archives of General Psychiatry, 65(5), 513520.
El-Mallakh, R. S., Waltrip, C., & Peters, C. (1999). Can long-term antidepressant use be depressogenic? Journal of Clinical Psychiatry, 60(4), 263263.
Fava, G. A. (2003). Can long-term treatment with antidepressant drugs worsen the course of depression? Journal of Clinical Psychiatry, 64, 123133.
Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015). Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: A systematic review. Psychotherapy and Psychosomatics, 84(2), 7281.
Fournier, J. C., DeRubeis, R. J., Shelton, R. C., Hollon, S. D., Amsterdam, J. D., & Gallop, R. (2009). Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. Journal of Consulting and Clinical Psychology, 77(4), 775787.
Furukawa, T. A., Cipriani, A., Atkinson, L. Z., Leucht, S., Ogawa, Y., Takeshima, N., … Salanti, G. (2016). Placebo response rates in antidepressant trials: A systematic review of published and unpublished double-blind randomised controlled studies. The Lancet. Psychiatry, 3(11), 10591066.
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003). Relapse prevention with antidepressant drug treatment in depressive disorders: A systematic review. Lancet, 361(9358), 653661.
Geddes, J. R., & Cipriani, A. (2015). Time to abandon placebo control in pivotal phase III trials? World Psychiatry, 14(3), 306307.
Glue, P., Donovan, M. R., Kolluri, S., & Emir, B. (2010). Meta-analysis of relapse prevention antidepressant trials in depressive disorders. Australian and New Zealand Journal of Psychiatry, 44(8), 697705.
Goldberg, D., Privett, M., Ustun, B., Simon, G., & Linden, M. (1998). The effects of detection and treatment on the outcome of major depression in primary care: a naturalistic study in 15 cities. British Journal of General Practice, 48(437), 18401844.
Gotschke, P. (2013). Deadly medicines and organised crime. London: Radcliffe Publishing.
Gotzsche, P. C. (2014). Why I think antidepressants cause more harm than good. The Lancet. Psychiatry, 1(2), 104106.
Greenhouse, J., & Meyer, M. (1991). A note on randomization and selection bias in maintenance therapy clinical-trials. Psychopharmacology Bulletin, 27(3), 225229.
Hansen, R., Gaynes, B., Thieda, P., Gartlehner, G., Deveaugh-Geiss, A., Krebs, E., & Lohr, K. (2008). Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants. Psychiatric Services, 59(10), 11211130.
Hardeveld, F., Spijker, J., De Graaf, R., Nolen, W. A., & Beekman, A. T. F. (2010). Prevalence and predictors of recurrence of major depressive disorder in the adult population. Acta Psychiatrica Scandinavica, 122(3), 184191.
Hengartner, M. P., Angst, J., & Roessler, W. (2018). Antidepressant use prospectively relates to a poorer long-term outcome of depression: Results from a prospective community cohort study over 30 years. Psychotherapy and Psychosomatics, 87(3), 181183.
Hieronymus, F., Emilsson, J. F., Nilsson, S., & Eriksson, E. (2016a). Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression. Molecular Psychiatry, 21(4), 523530.
Hieronymus, F., Nilsson, S., & Eriksson, E. (2016b). A mega-analysis of fixed-dose trials reveals dose-dependency and a rapid onset of action for the antidepressant effect of three selective serotonin reuptake inhibitors. Translational Psychiatry, 6, e834.
Hughes, S., & Cohen, D. (2009). A systematic review of long-term studies of drug treated and non-drug treated depression. Journal of Affective Disorders, 118(1–3), 918.
Huijbers, M. J., Spinhoven, P., Spijker, J., Ruhe, H. G., van Schaik, D. J. F., van Oppen, P., et al. (2016). Discontinuation of antidepressant medication after mindfulness-based cognitive therapy for recurrent depression: randomised controlled non-inferiority trial. British Journal of Psychiatry, 208(4), 366, -+.
Jakobsen, J. C., Katakam, K. K., Schou, A., Hellmuth, S. G., Stallknecht, S. E., Leth-Moller, K., et al. (2017). Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. BMC Psychiatry, 17, 58.
Kaymaz, N., van Os, J., Loonen, A. J. M., & Nolen, W. A. (2008). Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: A meta-analysis of placebo-controlled randomized trials. Journal of Clinical Psychiatry, 69(9), 1423, -+.
Kessler, R. C. (2018). The potential of predictive analytics to provide clinical decision support in depression treatment planning. Current Opinion in Psychiatry, 31(1), 3239.
Khin, N. A., Chen, Y., Yang, Y., Yang, P., & Laughren, T. P. (2011). Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US food and drug administration in support of new drug applications. Journal of Clinical Psychiatry, 72(4), 464472.
Kirsch, I. (2014). Antidepressants and the placebo effect. Zeitschrift Fur Psychologie – Journal of Psychology, 222(3), 128134.
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008). Initial severity and antidepressant benefits: a meta-analysis of data submitted to the food and drug administration. PLoS Medicine, 5(2), 260268.
Kuyken, W., Hayes, R., Barrett, B., Byng, R., Dalgleish, T., Kessler, D., … Byford, S. (2015). Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial. Lancet, 386(9988), 6373.
Kuyken, W., Warren, F. C., Taylor, R. S., Whalley, B., Crane, C., Bondolfi, G., et al. (2016). Efficacy of mindfulness-based cognitive therapy in prevention of depressive relapse an individual patient data meta-analysis from randomized trials. JAMA Psychiatry, 73(6), 565574.
Leucht, S., Hierl, S., Kissling, W., Dold, M., & Davis, J. M. (2012). Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses. British Journal of Psychiatry, 200(2), 97106.
Levkovitz, Y., Tedeschini, E., & Papakostas, G. I. (2011). Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials. Journal of Clinical Psychiatry, 72(4), 509514.
Linde, K., Kriston, L., Ruecker, G. et al. (2015). Efficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysis. Annals of Family Medicine, 13, 6979.
Lockhart, P., & Guthrie, B. (2011). Trends in primary care antidepressant prescribing 1995–2007: a longitudinal population database analysis. British Journal of General Practice, 61, 590.
Martens, E. P., Pestman, W. R., de Boer, A., Belitser, S. V., & Klungel, O. H. (2006). Instrumental variables application and limitations. Epidemiology, 17(3), 260267.
Mattisson, C., Bogren, M., Horstmann, V., Munk-Jorgensen, P., & Nettelbladt, P. (2007). The long-term course of depressive disorders in the Lundby Study. Psychological Medicine, 37(6), 883891.
Meadows, G.N., Prodan, A., Patten, S., Shawyer, F., Francis, S., Enticott, J., et al. (2019). Resolving the paradox of increased mental health expenditure and stable prevalence. Australian and New Zealand Journal of Medicine, 53(9), 844850.
Mellers, B., Hertwig, R., & Kahneman, D. (2001). Do frequency representations eliminate conjunction effects? An exercise in adversarial collaboration. Psychological Science, 12(4), 269275.
Mojtabai, R., & Olfson, M. (2014). National trends in long-term use of antidepressant medications: results from the US national health and nutrition examination survey. Journal of Clinical Psychiatry, 75(2), 169177.
Moncrieff, J. (2002). The antidepressant debate continues – reply. British Journal of Psychiatry, 181, 531531.
Moncrieff, J. (2003). A comparison of antidepressant trials using active and inert placebos. International Journal of Methods in Psychiatric Research, 12(3), 117127.
Moncrieff, J. (2018a). Research on a ‘drug-centred’ approach to psychiatric drug treatment: assessing the impact of mental and behavioural alterations produced by psychiatric drugs. Epidemiology and Psychiatric Sciences, 27(2), 133140.
Moncrieff, J. (2018b). What does the latest meta-analysis really tell us about antidepressants? Epidemiology and Psychiatric Sciences, 27(5), 430432.
Moncrieff, J., & Kirsch, I. (2015). Empirically derived criteria cast doubt on the clinical significance of antidepressant-placebo differences. Contemporary Clinical Trials, 43, 6062.
Mulder, R. T., & Frampton, C. M. A. (2014). Outcome of mood disorders before psychopharmacology: a systematic review. Australian and New Zealand Journal of Psychiatry, 48(3), 224236.
Murray, V., von Arbin, M., Bartfai, A., Berggren, A., Landtblom, A., Lundmark, J., et al. (2005). Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. Journal of Clinical Psychiatry, 66(6), 708716.
NICE. (2011). Common mental health disorders: identification and pathways to care. Clin. Guidel. 123, Natl. Inst. Clin. Excell., London.
Nuijen, J., ten Have, M., Tuithof, M., van Dorsselaer, S., & van Bon-Martens, M. (2014). Geen gebruik van professionele zorg bij stemmings-en angststoornissen: zorgelijk of niet? Resultaten van de ‘Netherlands Mental Health survey and incidence stuy-2 (NEMESIS-2)’. [No professional treatment use with anxiety and mood-disorders: a problem or not? Results of the ‘Netherlands Mental Health survey and incidence stuy-2 (NEMESIS-2)’., Netherlands Institute of Mental Health and Addiction (Trimbos institute), Utrecht, The Netherlands.
Nutt, D. J., Goodwin, G. M., Bhugra, D., Fazel, S., & Lawrie, S. (2014). Attacks on antidepressants: signs of deep-seated stigma? The Lancet. Psychiatry, 1(2), 102104.
Ormel, J., Oldehinkel, A. J., Brilman, E. I., & van den Brink, W. (1993). Outcome of depression and anxiety in primary care: a three-wave 3 ½-year study of psychopathology and disability. Archives of General Psychiatry, 50(10), 759766.
Piccinelli, M., & Wilkinson, G. (1994). Outcome of depression in psychiatric settings. British Journal of Psychiatry, 164, 297304.
Pigott, H. E., Leventhal, A. M., Alter, G. S., & Boren, J. J. (2010). Efficacy and effectiveness of antidepressants: current status of research. Psychotherapy and Psychosomatics, 79(5), 267279.
Pratt, L. A., Brody, D. J., & Gu, Q. (2017). Antidepressant use among persons aged 12 and over: United States, 2011–2014. NCHS Data Brief, No. 283, 18.
Quitkin, F. M., Rabkin, J. G., Gerald, J., Davis, J. M., & Klein, D. F. (2000). Validity of clinical trials of antidepressants. American Journal of Psychiatry, 157(3), 327337.
Regier, D. A., Kaelber, C. T., Rae, D. S., Farmer, M. E., Knauper, B., Kessler, R. C., & Norquist, G. S. (1998). Limitations of diagnostic criteria and assessment instruments for mental disorders. Implications for research and policy. Archives of General Psychiatry, 55, 109115.
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., et al. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. American Journal of Psychiatry, 163(11), 19051917.
Rutherford, B. R., & Roose, S. P. (2013). A model of placebo response in antidepressant clinical trials. American Journal of Psychiatry, 170(7), 723733.
Sareen, J., Henriksen, C. A., Stein, M. B., Afifi, T. O., Lix, L. M., & Enns, M. W. (2013). Common mental disorder diagnosis and need for treatment are not the same: Findings from a population-based longitudinal survey. Psychological Medicine, 43(9), 19411951.
Segal, Z. V., Bieling, P., Young, T., MacQueen, G., Cooke, R., Martin, L., … Levitan, R. D. (2010). Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression. Archives of General Psychiatry, 67(12), 12561264.
Sim, K., Lau, W. K., Sim, J., Sum, M. Y., & Baldessarini, R. J. (2016). Prevention of relapse and recurrence in adults with major depressive disorder: systematic review and meta-analyses of controlled trials. International Journal of Neuropsychopharmacology, 19(2), 113.
Spijker, J., de Graaf, R., Bijl, R. V., Beekman, A. T. F., Ormel, J., & Nolen, W. A. (2002). Duration of major depressive episodes in the general population: results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). British Journal of Psychiatry, 181, 208213.
Spijker, J., Meeuwissen, J., Aalbers, S., van Avendonk, M., van Bon, M., Huson, A., et al. (2019). De zorgstandaard Depressieve stoornissen. Tijdschrift voor Psychiatrie, 61(2), 112120.
Steinert, C., Hofmann, M., Kruse, J., & Leichsenring, F. (2014). The prospective long-term course of adult depression in general practice and the community. A systematic literature review. Journal of Affective Disorders, 152, 6575.
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008). Selective publication of antidepressant trials and its influence on apparent efficacy. New England Journal of Medicine, 358(3), 252260.
Van der Lem, R., van der Wee, N. J. A., Van Veen, T., & Zitman, F. G. (2012). Ëfficacy versus effectiveness: a direct comparison of the outcome of treatment for mild to moderate depression in randomized controlled trials and daily practice. Psychotherapy and Psychosomatics, 81, 226234.
van Weel-Baumgarten, E. M., Schers, H. J., van den Bosch, W. J., van den Hoogen, H. J., & Zitman, F. G. (2000). Long-term follow-up of depression among patients in the community and in family practice settings – a systematic review. Journal of Family Practice, 49(12), 11131120.
Verduijn, J., Verhoeven, J. E., Milaneschi, Y., Schoevers, R. A., van Hemert, A. M., Beekman, A. T. F., & Penninx, B. W. J. H (2017). Reconsidering the prognosis of major depressive disorder across diagnostic boundaries: Full recovery is the exception rather than the rule. BMC Medicine, 15, 215.
Vittengl, J. R. (2017). Poorer long-term outcomes among persons with major depressive disorder treated with medication. Psychotherapy and Psychosomatics, 86(5), 302304.
Vittengl, J. R., Clark, L. A., Dunn, T. W., & Jarrett, R. B. (2007). Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects. Journal of Consulting and Clinical Psychology, 75(3), 475488.
Wang, Y., Henriksen, C. A., ten Have, M., de Graaf, R., Stein, M. B., Enns, M. W., & Sareen, J. (2017). Common mental disorder diagnosis and need for treatment are not the same: Findings from the NEMESIS study. Administration and Policy in Mental Health and Mental Health Services Research, 44(4), 572581.
Whitaker, R. (2015). Anatomy of an epidemic. New York: Broadway Books.
Whiteford, H. A., Harris, M. G., McKeon, G., Baxter, A., Pennell, C., Barendregt, J. J., & Wang, J. (2013). Estimating remission from untreated major depression: A systematic review and meta-analysis. Psychological Medicine, 43(8), 15691585.
Wildeboer, R. M., van der Hoek, L., & Verhaak, P. F. M. (2016). Use of general practice services 5 years after an episode of mental illness: Case-control study using electronic records. British Journal of General Practice, 66(646), E347E353.
Zimmerman, M., Posternak, M. A., & Ruggero, C. J. (2007). Impact of study design on the results of continuation studies of antidepressants. Journal of Clinical Psychopharmacology, 27(2), 177181.

Keywords

The antidepressant standoff: why it continues and how to resolve it

  • Johan Ormel (a1) (a2), Philip Spinhoven (a2) (a3), Ymkje Anna de Vries (a4), Angélique O. J. Cramer (a2) (a5), Greg J. Siegle (a6), Claudi L. H. Bockting (a2) (a7) and Steven D. Hollon (a8)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed